4jzc
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Angiopoietin-2 fibrinogen domain TAG mutant== | ==Angiopoietin-2 fibrinogen domain TAG mutant== | ||
- | <StructureSection load='4jzc' size='340' side='right' caption='[[4jzc]], [[Resolution|resolution]] 1.90Å' scene=''> | + | <StructureSection load='4jzc' size='340' side='right'caption='[[4jzc]], [[Resolution|resolution]] 1.90Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4jzc]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4jzc]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JZC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4JZC FirstGlance]. <br> |
- | </td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4jzc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jzc OCA], [https://pdbe.org/4jzc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4jzc RCSB], [https://www.ebi.ac.uk/pdbsum/4jzc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4jzc ProSAT]</span></td></tr> |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/ANGP2_HUMAN ANGP2_HUMAN] Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANGPT1. In the absence of angiogenic inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF, it may facilitate endothelial cell migration and proliferation, thus serving as a permissive angiogenic signal.<ref>PMID:9204896</ref> <ref>PMID:15284220</ref> <ref>PMID:19116766</ref> <ref>PMID:19223473</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Barton | + | [[Category: Large Structures]] |
- | [[Category: Dalton | + | [[Category: Barton WA]] |
- | [[Category: Goldgur | + | [[Category: Dalton AC]] |
- | [[Category: Nikolov | + | [[Category: Goldgur Y]] |
- | [[Category: Seegar | + | [[Category: Nikolov DB]] |
- | [[Category: Tzvetkova-Robev | + | [[Category: Seegar TCM]] |
- | [[Category: Yu | + | [[Category: Tzvetkova-Robev D]] |
- | + | [[Category: Yu X]] | |
- | + | ||
- | + | ||
- | + |
Revision as of 11:31, 30 November 2022
Angiopoietin-2 fibrinogen domain TAG mutant
|